Mitral valve repair with bypass surgery may improve heart function

February 29, 2012

Patients who had leaky mitral heart valves repaired along with bypass surgery had with healthier hearts than those who had bypass only, according to new research presented in the American Heart Association's Emerging Science Series webinar.

The mitral valve separates the heart's left atrium (upper chamber) from the left ventricle (lower chamber). It has two flaps, or cusps, and if the flaps don't close properly, the valve will leak.

"Many patients who need bypass surgery have mild to moderately leaky mitral valves because coronary artery disease causes the heart to enlarge and, in the process, pulls the mitral valve apart," said K. M. John Chan, B.M.B.S., F.R.C.S., C.Th., the study's lead author and a senior clinical research fellow at Imperial College in London, U.K. The patients in this study had a specific type of mitral valve leak called functional ischemic mitral regurgitation.

The dual procedures of valve repair and coronary artery bypass graft surgery (CABG) are typically reserved for patients with severely leaking valves. However, patients with moderately leaking valves who had both procedures had more improved exercise capacity and heart functioning, and their hearts were more likely to return to a more normal size than those with CABG-surgery alone.

Blood markers associated with heart failure also improved for patients who had the dual surgeries versus CABG-only patients.

Even though surgeons don't typically repair valves with moderate leaks during bypass, CABG patients with leaky mitral valves fare more poorly after surgery than patients whose valves don't leak, Chan said.

Researchers randomized 60 patients to receive CABG only or CABG and mitral valve repair. All patients had moderate mitral valve leaks caused by ischemic heart disease. They tested patients' exercise capacity, heart function and heart size before and one year after surgery.

In the year after surgery:
-end-
John R. Pepper, M.Chir., F.R.C.S., is co-author of the study. Author disclosures are on the abstract.

The U.K. Department of Health, British Heart Foundation and British Medical Association funded the study.

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.

NR12 - 1034 (ESS/Chan)

Additional Resources:

American Heart Association

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.